Suppr超能文献

阴道毛滴虫感染的鼠类模型。

Murine models of vaginal trichomonad infections.

机构信息

Department of Pathology, School of Medicine, University of California San Diego, USA.

出版信息

Am J Trop Med Hyg. 2011 Oct;85(4):667-73. doi: 10.4269/ajtmh.2011.11-0123.

Abstract

Trichomonas vaginalis and Tritrichomonas foetus cause common sexually transmitted infections in humans and cattle, respectively. Mouse models of trichomoniasis are important for pathogenic and therapeutic studies. Here, we compared murine genital infections with T. vaginalis and T. foetus. Persistent vaginal infection with T. foetus was established with 100 parasites but T. vaginalis infection required doses of 10(6), perhaps because of greater susceptibility to killing by mouse vaginal polymorphonuclear leukocytes. Infection with T. vaginalis persisted longest after combined treatment of mice with estrogen and dexamethasone, whereas infection was only short-lived when mice were given estrogen or dexamethasone alone, co-infected with Lactobacillus acidophilus, and/or pretreated with antibiotics. Infection rates were similar with metronidazole-resistant (MR) and metronidazole-sensitive (MS) T. vaginalis. High dose but not low dose metronidazole treatment controlled infection with MS better than MR T. vaginalis. These murine models will be valuable for investigating the pathogenesis and treatment of trichomoniasis.

摘要

阴道毛滴虫和胎儿三毛滴虫分别引起人类和牛的常见性传播感染。阴道毛滴虫病的小鼠模型对于发病机制和治疗研究非常重要。在这里,我们比较了 T. vaginalis 和 T. foetus 引起的小鼠生殖道感染。用 100 个虫体建立了 T. foetus 的持续性阴道感染,但 T. vaginalis 感染需要 10(6)个虫体,这可能是因为阴道多形核白细胞更容易杀死 T. vaginalis。当用雌激素和地塞米松联合处理小鼠时,T. vaginalis 的感染持续时间最长,而当小鼠单独用雌激素或地塞米松、与嗜酸乳杆菌共同感染或用抗生素预处理时,感染时间很短。耐甲硝唑(MR)和甲硝唑敏感(MS)T. vaginalis 的感染率相似。高剂量而非低剂量甲硝唑治疗对 MS T. vaginalis 的控制效果优于 MR T. vaginalis。这些小鼠模型将有助于研究阴道毛滴虫病的发病机制和治疗方法。

相似文献

1
Murine models of vaginal trichomonad infections.
Am J Trop Med Hyg. 2011 Oct;85(4):667-73. doi: 10.4269/ajtmh.2011.11-0123.
2
Vaginal Tritrichomonas foetus infection in mice as an in vivo model for drug development against Trichomonas vaginalis.
PLoS One. 2024 Oct 1;19(10):e0308672. doi: 10.1371/journal.pone.0308672. eCollection 2024.
3
Use of an animal model of trichomoniasis as a basis for understanding this disease in women.
Clin Infect Dis. 1995 Oct;21 Suppl 2:S158-61. doi: 10.1093/clinids/21.supplement_2.s158.
4
Anti-trichomonad activities of different compounds from foods, marine products, and medicinal plants: a review.
BMC Complement Med Ther. 2020 Sep 9;20(1):271. doi: 10.1186/s12906-020-03061-9.
5
Female reproductive tract immunity in bovine trichomoniasis.
Am J Reprod Immunol. 1998 Mar;39(3):189-98. doi: 10.1111/j.1600-0897.1998.tb00353.x.
7
Persistent Trichomonas vaginalis infections and the pseudocyst form.
Trends Parasitol. 2023 Dec;39(12):1023-1031. doi: 10.1016/j.pt.2023.09.009. Epub 2023 Oct 6.
8
Trichomonads, hydrogenosomes and drug resistance.
Int J Parasitol. 1999 Feb;29(2):199-212. doi: 10.1016/s0020-7519(98)00155-6.
9
Auranofin inactivates Trichomonas vaginalis thioredoxin reductase and is effective against trichomonads in vitro and in vivo.
Int J Antimicrob Agents. 2016 Dec;48(6):690-694. doi: 10.1016/j.ijantimicag.2016.09.020. Epub 2016 Nov 2.
10
Development of a nonhuman primate model for Trichomonas vaginalis infection.
Sex Transm Dis. 2006 Dec;33(12):743-6. doi: 10.1097/01.olq.0000218871.89901.61.

引用本文的文献

3
Vaginal Tritrichomonas foetus infection in mice as an in vivo model for drug development against Trichomonas vaginalis.
PLoS One. 2024 Oct 1;19(10):e0308672. doi: 10.1371/journal.pone.0308672. eCollection 2024.
4
Neutrophils versus Protozoan Parasites: , , , , and .
Microorganisms. 2024 Apr 19;12(4):827. doi: 10.3390/microorganisms12040827.
6
Trichomonas vaginalis adherence phenotypes and extracellular vesicles impact parasite survival in a novel in vivo model of pathogenesis.
PLoS Negl Trop Dis. 2023 Oct 23;17(10):e0011693. doi: 10.1371/journal.pntd.0011693. eCollection 2023 Oct.
7
Infinity war: and interactions with host immune response.
Microb Cell. 2023 Mar 30;10(5):103-116. doi: 10.15698/mic2023.05.796. eCollection 2023 May 1.
8
Fucose Ameliorates sp.-Associated Illness in Antibiotic-Treated Mice.
Int J Mol Sci. 2021 Oct 2;22(19):10699. doi: 10.3390/ijms221910699.
9
Gold(I) Phosphine Derivatives with Improved Selectivity as Topically Active Drug Leads to Overcome 5-Nitroheterocyclic Drug Resistance in .
J Med Chem. 2021 May 27;64(10):6608-6620. doi: 10.1021/acs.jmedchem.0c01926. Epub 2021 May 11.
10
Deazapurine Nucleoside Analogues for the Treatment of .
ACS Infect Dis. 2021 Jun 11;7(6):1752-1764. doi: 10.1021/acsinfecdis.1c00075. Epub 2021 May 11.

本文引用的文献

2
A pregnant mouse model for bovine Tritrichomonas foetus infection.
Vet Pathol. 2008 Nov;45(6):849-64. doi: 10.1354/vp.45-6-849.
4
Draft genome sequence of the sexually transmitted pathogen Trichomonas vaginalis.
Science. 2007 Jan 12;315(5809):207-12. doi: 10.1126/science.1132894.
5
The activity of protease inhibitors against Giardia duodenalis and metronidazole-resistant Trichomonas vaginalis.
Int J Antimicrob Agents. 2007 Jan;29(1):98-102. doi: 10.1016/j.ijantimicag.2006.08.026. Epub 2006 Nov 29.
6
Prevalence of Trichomonas vaginalis isolates with resistance to metronidazole and tinidazole.
Antimicrob Agents Chemother. 2006 Dec;50(12):4209-10. doi: 10.1128/AAC.00814-06. Epub 2006 Sep 25.
7
Trichomoniasis and its treatment.
Expert Rev Anti Infect Ther. 2006 Feb;4(1):125-35. doi: 10.1586/14787210.4.1.125.
10
Drug resistance in the sexually transmitted protozoan Trichomonas vaginalis.
Cell Res. 2003 Aug;13(4):239-49. doi: 10.1038/sj.cr.7290169.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验